RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Thanks, Erbse. So we can add Sanofi-Aventis to the growing list of companies with AMPA upregulating programs. It looks like dipyrazoles affect NMDA activity also.

A few other AMPA programs are Boehringer Ingelheim's which has been around for a while (now with something called BIIR-777). There's also "Stargazin", which is a TARP (Transmembrane AMPA Receptor Regulatory Protein), which is apparently involved in the surface delivery and anchoring of AMPA receptors, and may also be an allosteric modulator.